Synopsis
Synopsis
0
VMF
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Alpha Heparin
2. Alpha-heparin
3. Heparin
4. Heparin Sodium
5. Heparin, Sodium
6. Heparin, Unfractionated
7. Heparinic Acid
8. Liquaemin
9. Unfractionated Heparin
1. (2s,3s,4r,5r,6r)-6-{[(2s,3s,4s,5r,6s)-6-{[(2r,3s,4s,5r)-2-carboxy-4,6-dihydroxy-5-(sulfooxy)oxan-3-yl]oxy}-2-hydroxy-4-(sulfomethyl)-5-(sulfooxy)oxan-3-yl]oxy}-3-{[(2r,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-4,5-dihydroxyoxane-2-carboxylic Acid
2. Hepflush
3. Chembl526514
4. Gtpl4214
5. S01xa14
6. Bdbm50480251
7. (2s,3s,4r,5r,6r)-3-[(2r,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2s,3s,4s,5r,6s)-6-[(2r,3s,4s,5r)-2-carboxy-4,6-dihydroxy-5-sulfooxyoxan-3-yl]oxy-2-hydroxy-4-(sulfomethyl)-5-sulfooxyoxan-3-yl]oxy-4,5-dihydroxyoxane-2-carboxylic Acid
1. 9005-49-6
Molecular Weight | 1039.9 g/mol |
---|---|
Molecular Formula | C26H41NO34S4 |
XLogP3 | -10.4 |
Hydrogen Bond Donor Count | 14 |
Hydrogen Bond Acceptor Count | 34 |
Rotatable Bond Count | 18 |
Exact Mass | 1039.0392821 g/mol |
Monoisotopic Mass | 1039.0392821 g/mol |
Topological Polar Surface Area | 589 Ų |
Heavy Atom Count | 65 |
Formal Charge | 0 |
Complexity | 2140 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 19 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Heparin sodium |
Drug Label | Intravenous solutions with heparin sodium (derived from porcine intestinal mucosa) are sterile, nonpyrogenic fluids for intravenous administration. They contain no bacteriostat or antimicrobial agent or added buffer. Edetate disodium, anhydrous is ad... |
Active Ingredient | Heparin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | 5,000 units/ml; 10,000 units/ml; 20,000 units/ml; 1,000 units/ml |
Market Status | Prescription |
Company | Hospira; Shenzhen Techdow; Sandoz; Pfizer; Fresenius Kabi Usa; Hikma Maple; Sagent Pharms |
2 of 2 | |
---|---|
Drug Name | Heparin sodium |
Drug Label | Intravenous solutions with heparin sodium (derived from porcine intestinal mucosa) are sterile, nonpyrogenic fluids for intravenous administration. They contain no bacteriostat or antimicrobial agent or added buffer. Edetate disodium, anhydrous is ad... |
Active Ingredient | Heparin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | 5,000 units/ml; 10,000 units/ml; 20,000 units/ml; 1,000 units/ml |
Market Status | Prescription |
Company | Hospira; Shenzhen Techdow; Sandoz; Pfizer; Fresenius Kabi Usa; Hikma Maple; Sagent Pharms |
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
Fibrinolytic Agents
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31738
Submission : 2017-05-17
Status : Active
Type : II
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26680
Submission : 2013-01-07
Status : Active
Type : II
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
GDUFA
DMF Review : Complete
Rev. Date : 2013-05-09
Pay. Date : 2013-04-26
DMF Number : 17838
Submission : 2004-11-03
Status : Active
Type : II
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9472
Submission : 1991-12-23
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5878
Submission : 1985-05-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-10-11
Pay. Date : 2022-08-16
DMF Number : 36291
Submission : 2021-09-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34686
Submission : 2020-03-17
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-07-16
Pay. Date : 2018-06-28
DMF Number : 9131
Submission : 1991-05-09
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-09-15
Pay. Date : 2020-09-14
DMF Number : 2712
Submission : 1976-08-03
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1007
Submission : 1966-11-01
Status : Inactive
Type : II
Certificate Number : R0-CEP 2004-080 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2005-08-03
Type : Chemical
Substance Number : 333
Certificate Number : R1-CEP 2002-012 - Rev 06
Status : Valid
Issue Date : 2020-10-08
Type : Chemical
Substance Number : 333
Certificate Number : R0-CEP 2002-044 - Rev 01
Status : Expired
Issue Date : 2005-03-02
Type : TSE
Substance Number : 332
Certificate Number : R0-CEP 2002-043 - Rev 01
Status : Expired
Issue Date : 2005-03-02
Type : TSE
Substance Number : 333
Certificate Number : R1-CEP 2001-445 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2011-03-30
Type : Chemical
Substance Number : 333
Heparin sodium, For parenteral preparations, European and Chilean origin
Certificate Number : R1-CEP 2001-446 - Rev 03
Status : Valid
Issue Date : 2020-02-21
Type : Chemical
Substance Number : 333
Heparin sodium, For parenteral preparations
Certificate Number : R1-CEP 2002-006 - Rev 09
Status : Valid
Issue Date : 2022-01-12
Type : Chemical
Substance Number : 333
Certificate Number : R1-CEP 2001-243 - Rev 01
Status : Valid
Issue Date : 2011-05-03
Type : Chemical
Substance Number : 333
Certificate Number : R1-CEP 2003-163 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2009-07-17
Type : Chemical
Substance Number : 333
Certificate Number : R0-CEP 2001-034 - Rev 01
Status : Expired
Issue Date : 2005-03-10
Type : TSE
Substance Number : 333
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
About the Company : Bioiberica is a global Life Science company with more than 45 years' experience in the production and development of molecules of high biological and therapeutic value for the phar...
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
About the Company : Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs ...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Aspen API is the cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. With quality, compliance, and teamwork at its core, Aspen...
About the Company : Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical indu...
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs)...
About the Company : Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.
...
About the Company : For more than 45 years, Bacto Chem has stood as a pioneer in the field of bio-pharmaceutical products and formulations. Established in 1972 in Hyderabad, Telangana, by the late D...
About the Company : Syntex is an Argentine company that elaborates active ingredients from biological and semi-synthetic origins for Human and Veterinary Pharmaceutical Industry since 1935. We work wi...
About the Company : QINGDAO QINGMEI BIOTECH(hereinafter referred to as Qingmei) is a specialized pharmaceutical company founded by DAYON INTERNATIONAL HOLDING LIMITED, which is to expand international...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 9041-08-1
End Use API : Heparin Sodium
About The Company : Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the...
CAS Number : 9041-08-1
End Use API : Heparin Sodium
About The Company : Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the...
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALCIPARINE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 25,000 UNITS/ML
Packaging :
Approval Date : 1982-01-01
Application Number : 18237
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Thrombophob Gel
Dosage Form : JEL
Dosage Strength : 20000IU/100g
Packaging : 25X1IU/100g
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LIQUAEMIN SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20,000 UNITS/ML
Packaging :
Approval Date : 1982-01-01
Application Number : 552
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LIQUAEMIN SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 40,000 UNITS/ML
Packaging :
Approval Date : 1982-01-01
Application Number : 552
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LIQUAEMIN SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1,000 UNITS/ML
Packaging :
Approval Date : 1982-01-01
Application Number : 552
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LIQUAEMIN SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10,000 UNITS/ML
Packaging :
Approval Date : 1982-01-01
Application Number : 552
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HEPARIN SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1,000 UNITS/ML
Packaging :
Approval Date : 1982-01-01
Application Number : 552
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HEPARIN SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 5,000 UNITS/ML
Packaging :
Approval Date : 1982-01-01
Application Number : 552
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HEPARIN SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10,000 UNITS/ML
Packaging :
Approval Date : 1982-01-01
Application Number : 552
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LIQUAEMIN SODIUM PRESERVATIVE FREE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1,000 UNITS/ML
Packaging :
Approval Date : 1986-04-11
Application Number : 552
Regulatory Info : DISCN
Registration Country : USA
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Tablet
Grade : Parenteral, Oral, Topical
Category : Parenteral, Solubilizers, Topical
Dosage Form : Cream / Lotion / Ointment, Injectable / Parenteral
Grade : Parenteral and Topical
Category : Parenteral, Topical
Application : Parenteral, Topical
Brand Name : Hydrochloric Acid NF
Application : Parenteral
Excipient Details : A&C's Hydrochloric Acid NF is used as a low pH neutralizing agent for pharmaceutical applications.
Brand Name : Sodium Chloride USP
Application : Parenteral
Excipient Details : A & C's Sodium Chloride is an excipient meeting the USP monograph.
Brand Name : Microlex® DX-Inj 500
Application : Parenteral
Excipient Details : It is used as Diurectic-osmotic for injectable solution, Dialysis solution, Injectible and Parenteral solution.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/...
Technical Specs : Not Available
Ingredient(s) : Dextrose
Brand Name : NaCl Multi-compendial Low Endotoxin
Application : Parenteral
Excipient Details : A & C's Sodium Chloride multi-compendial low endotoxin is an excipient meeting USP-NF, EP, BP and JP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Low Endotoxin
Ingredient(s) : Sodium Chloride Excipient
Brand Name : LYCADEX® BIOPHARMA
Application : Parenteral
Excipient Details : It is used upstream in the cell culture process as an energy and carbon source during the production of therapeutic proteins
Pharmacopoeia Ref : EP/USP
Technical Specs : Not Available
Ingredient(s) : Dextrose Monohydrate, low endotoxin
Application : Parenteral
Excipient Details : It is a dextrose monohydrate pyrogen-free that is a physiological sugar used to provide excipient and API benefits.
Global Sales Information
Market Place
Reply
18 Nov 2024
Reply
26 Oct 2024
Reply
14 Jun 2024
Reply
12 Jun 2024
Reply
22 Mar 2024
Reply
14 Mar 2024
Reply
18 Sep 2023
Reply
06 Jul 2023
Reply
17 Jun 2023
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?